Search - tctmd.com

Displaying 121 - 140 of 197

Sort: Relevancy | Date

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Industry News

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

May 24, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

L.A. McKeown

May 15, 2018

News Featured Fellow

Shivanshu Madan, MD

Yael L. Maxwell

May 14, 2018

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Todd Neale

May 14, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Conference News HRS 2018

CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation

Todd Neale

May 10, 2018

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Caitlin E. Cox

May 09, 2018

News Industry News

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

May 08, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Daily News

LPA Variants Linked With CHD Events in Statin-Treated Patients

Michael O'Riordan

May 03, 2018

News Daily News

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

Todd Neale

May 02, 2018

News Conference News SCAI 2018

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Yael L. Maxwell

April 26, 2018

News Conference News SCAI 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

L.A. McKeown

April 26, 2018

News Industry News

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

April 25, 2018

Advertisement

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

Shivanshu Madan, MD

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

LPA Variants Linked With CHD Events in Statin-Treated Patients

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content